PDCD1 and cancer: To evaluate our method’s ability to predict therapeutic targets for uses in combination with anti-PD-1 therapies, we manually collected 155 target genes of 36 compounds that have been tested in clinical trials or used for combination treatments with anti-PD-1 therapies in cancer (Supplementary Data 5).